3004.90.92.50 - Laxatives 🖩

This HTS category, 3004.90.92.50, specifically covers laxative preparations. These are pharmaceutical products, whether in mixed or unmixed forms, that are intended for therapeutic or prophylactic use in treating or preventing constipation and promoting bowel regularity. They must be presented in measured doses, such as tablets, capsules, or liquid formulations, or in packaging suitable for direct sale to the end consumer. This classification applies to a broad range of laxatives, including bulk-forming agents, stool softeners, osmotic laxatives, and stimulant laxatives.

It is important to distinguish this subcategory from its siblings. While 3004.90.92.55 also falls under medicaments affecting the digestive system, it is designated for antacids. Similarly, 3004.90.92.56 and 3004.90.92.57 are specifically for medicaments containing particular active ingredients (famotidine and pantoprazole, respectively) that often address digestive system issues but are not exclusively defined by their laxative properties. The "Other" categories at this level are catch-alls for remaining medicaments affecting the digestive system not otherwise specified. This specific classification for laxatives ensures that products whose primary therapeutic function is to induce defecation are correctly identified.

As a leaf node within the HTS, this category does not have further subdivisions. Therefore, the primary classification criteria revolve around the identified therapeutic purpose of promoting bowel evacuation and the presentation of the goods in measured doses or retail packaging for sale as pharmaceutical products. The focus is on the inherent function of the preparation as a laxative.